Stay updated on ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial
Sign up to get notified when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.

Latest updates to the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page
- ChecktodayChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The clinical trial record itself is still unavailable.SummaryDifference1%

- Check7 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record. This reflects an access-state issue rather than a content update to the study details or related information.SummaryDifference20%

- Check57 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6 on the Study Details page, signaling a new version of the page rather than a change to study data.SummaryDifference0.0%

- Check71 days agoChange DetectedThe 2025-05-20 entry and the Certification/Extension First Posted label were removed from the Study Record Dates, updating the page's historical QC metadata rather than the trial details.SummaryDifference0.1%

Stay in the know with updates to ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.